147 related articles for article (PubMed ID: 37475642)
21. Association between non-alcoholic fatty liver disease and the risk of dementia: A nationwide cohort study.
Kim GA; Oh CH; Kim JW; Jeong SJ; Oh IH; Lee JS; Park KC; Shim JJ
Liver Int; 2022 May; 42(5):1027-1036. PubMed ID: 35289469
[TBL] [Abstract][Full Text] [Related]
22. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
[TBL] [Abstract][Full Text] [Related]
23. Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.
Mann JP; Carter P; Armstrong MJ; Abdelaziz HK; Uppal H; Patel B; Chandran S; More R; Newsome PN; Potluri R
PLoS One; 2020; 15(10):e0241357. PubMed ID: 33108366
[TBL] [Abstract][Full Text] [Related]
24. Association between non-alcoholic fatty liver disease and the risk of biliary tract cancers: A South Korean nationwide cohort study.
Park JH; Hong JY; Kwon M; Lee J; Han K; Han IW; Kang W; Park JK
Eur J Cancer; 2021 Jun; 150():73-82. PubMed ID: 33892409
[TBL] [Abstract][Full Text] [Related]
25. Increased risk of pancreatic cancer in individuals with non-alcoholic fatty liver disease.
Park JH; Hong JY; Han K; Kang W; Park JK
Sci Rep; 2022 Jun; 12(1):10681. PubMed ID: 35739172
[TBL] [Abstract][Full Text] [Related]
26. Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD).
Roderburg C; Krieg S; Krieg A; Demir M; Luedde T; Kostev K; Loosen SH
Eur J Med Res; 2023 Apr; 28(1):153. PubMed ID: 37062837
[TBL] [Abstract][Full Text] [Related]
27. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
Li Y; Zheng R; Li J; Feng S; Wang L; Huang Z
Lipids Health Dis; 2020 Oct; 19(1):229. PubMed ID: 33109219
[TBL] [Abstract][Full Text] [Related]
28. The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study.
Allen AM; Hicks SB; Mara KC; Larson JJ; Therneau TM
J Hepatol; 2019 Dec; 71(6):1229-1236. PubMed ID: 31470068
[TBL] [Abstract][Full Text] [Related]
29. Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort.
Choe HJ; Lee H; Lee D; Kwak SH; Koo BK
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):260-269. PubMed ID: 36403577
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic use and development of nonalcoholic fatty liver disease: A population-based case-control study.
Ebrahimi F; Simon TG; Hagström H; Sun J; Bergman D; Forss A; Roelstraete B; Engstrand L; Ludvigsson JF
Liver Int; 2023 Oct; 43(10):2186-2197. PubMed ID: 37387502
[TBL] [Abstract][Full Text] [Related]
31. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.
Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Hultcrantz R; Kechagias S
J Hepatol; 2017 Dec; 67(6):1265-1273. PubMed ID: 28803953
[TBL] [Abstract][Full Text] [Related]
32. Non-Alcoholic Fatty Liver Disease (NAFLD) and risk of new-onset heart failure: a retrospective analysis of 173,966 patients.
Roderburg C; Krieg S; Krieg A; Vaghiri S; Mohr R; Konrad M; Luedde M; Luedde T; Kostev K; Loosen SH
Clin Res Cardiol; 2023 Oct; 112(10):1446-1453. PubMed ID: 37410163
[TBL] [Abstract][Full Text] [Related]
33. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
[TBL] [Abstract][Full Text] [Related]
34. Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan.
Yoneda M; Yamamoto T; Honda Y; Imajo K; Ogawa Y; Kessoku T; Kobayashi T; Nogami A; Higurashi T; Kato S; Hosono K; Saito S; Nakajima A
J Gastroenterol; 2021 Nov; 56(11):1022-1032. PubMed ID: 34601620
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease.
Haflidadottir S; Jonasson JG; Norland H; Einarsdottir SO; Kleiner DE; Lund SH; Björnsson ES
BMC Gastroenterol; 2014 Sep; 14():166. PubMed ID: 25260964
[TBL] [Abstract][Full Text] [Related]
36. Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study.
Allen AM; Therneau TM; Larson JJ; Coward A; Somers VK; Kamath PS
Hepatology; 2018 May; 67(5):1726-1736. PubMed ID: 28941364
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States.
Golabi P; Paik J; Reddy R; Bugianesi E; Trimble G; Younossi ZM
BMC Gastroenterol; 2019 Apr; 19(1):56. PubMed ID: 30991959
[TBL] [Abstract][Full Text] [Related]
38. Severity of Nonalcoholic Fatty Liver Disease is Associated With Cardiovascular Outcomes in Patients With Prehypertension or Hypertension: A Community-Based Cohort Study.
Song QR; Liu SL; Ling QH; Gao QN; Yang RX; Chen SH; Wu SL; Chen ML; Cai J
Front Endocrinol (Lausanne); 2022; 13():942647. PubMed ID: 36093080
[TBL] [Abstract][Full Text] [Related]
39. Non-alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study.
Min YW; Kim Y; Gwak GY; Gu S; Kang D; Cho SJ; Guallar E; Cho J; Sinn DH
J Gastroenterol Hepatol; 2018 May; 33(5):1053-1058. PubMed ID: 29131401
[TBL] [Abstract][Full Text] [Related]
40. Associations between an inflammatory diet index and severe non-alcoholic fatty liver disease: a prospective study of 171,544 UK Biobank participants.
Petermann-Rocha F; Wirth MD; Boonpor J; Parra-Soto S; Zhou Z; Mathers JC; Livingstone K; Forrest E; Pell JP; Ho FK; Hébert JR; Celis-Morales C
BMC Med; 2023 Apr; 21(1):123. PubMed ID: 37013578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
